It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.

The man’s symptoms were intermittent, and he lived with them for years. Then he got scared enough to seek help.

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

The thorax houses major blood vessels responsible for systemic and pulmonary circulation. These vessels include the aorta, ...

For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, ...

The combining form "athero-" is used in several medical terms to describe conditions related to the accumulation of plaque or ...